prikaz prve stranice dokumenta Polypharmacy among the elderly in the Republic of Srpska: extent and implications for the future
  Preuzmi
PDF 518.8 KB
Znanstveni rad - Izvorni znanstveni rad
Polypharmacy among the elderly in the Republic of Srpska: extent and implications for the future
Expert Review of Pharmacoeconomics & Outcomes Research, 16 (2015), 5; 609-618. https://doi.org/10.1586/14737167.2016.1115347
Marković-Peković, Vanda; Škrbić, Ranko; Petrović, Aleksandar; Vlahović-Palčevski, Vera; Mrak, Jana; Bennie, Marion; Fadare, Joseph; Kwon, Hye-Young; Schiffers, Krijn; Truter, Ilse; Godman, Brian

Citiranost:
,
Citirajte ovaj rad

Marković Peković, V., Škrbić, R., Petrović, A., Vlahović Palčevski, V., Mrak, J., Bennie, M. ... Godman, B. (2015). Polypharmacy among the elderly in the Republic of Srpska: extent and implications for the future. Expert Review of Pharmacoeconomics & Outcomes Research, 16. (5), 609-618. doi: 10.1586/14737167.2016.1115347

Marković Peković, Vanda, et al. "Polypharmacy among the elderly in the Republic of Srpska: extent and implications for the future." Expert Review of Pharmacoeconomics & Outcomes Research, vol. 16, br. 5, 2015, str. 609-618. https://doi.org/10.1586/14737167.2016.1115347

Marković Peković, Vanda, Ranko Škrbić, Aleksandar Petrović, Vera Vlahović Palčevski, Jana Mrak, Marion Bennie, Joseph Fadare, et al. "Polypharmacy among the elderly in the Republic of Srpska: extent and implications for the future." Expert Review of Pharmacoeconomics & Outcomes Research 16, br. 5 (2015): 609-618. https://doi.org/10.1586/14737167.2016.1115347

Marković Peković, V., et al. (2015) 'Polypharmacy among the elderly in the Republic of Srpska: extent and implications for the future', Expert Review of Pharmacoeconomics & Outcomes Research, 16(5), str. 609-618. doi: 10.1586/14737167.2016.1115347

Marković Peković V, Škrbić R, Petrović A, Vlahović Palčevski V, Mrak J, Bennie M, i sur.. Polypharmacy among the elderly in the Republic of Srpska: extent and implications for the future. Expert Review of Pharmacoeconomics & Outcomes Research [Internet]. 15.12.2015. [pristupljeno 26.02.2025.];16(5):609-618. doi: 10.1586/14737167.2016.1115347

V. Marković Peković, et al., "Polypharmacy among the elderly in the Republic of Srpska: extent and implications for the future", Expert Review of Pharmacoeconomics & Outcomes Research, vol. 16, br. 5, str. 609-618, Prosinac 2015. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:184:499506. [Citirano: 26.02.2025.]

Za citiranje koristite ovu mrežnu adresu: https://urn.nsk.hr/urn:nbn:hr:184:499506
Prijavite se u repozitorij kako biste mogli spremiti objekt u svoju listu.
Podaci o radu
Naslov (engleski)Polypharmacy among the elderly in the Republic of Srpska: extent and implications for the future
AutorVanda Marković-Peković
AutorRanko Škrbić
AutorAleksandar Petrović
AutorVera Vlahović-Palčevski
AutorJana Mrak
AutorMarion Bennie
AutorJoseph Fadare
AutorHye-Young Kwon
AutorKrijn Schiffers
AutorIlse Truter
AutorBrian Godman
Autorova ustanovaSveučilište u Rijeci
Medicinski fakultet
(Katedra za farmakologiju)
Znanstveno / umjetničko
područje, polje i grana		BIOMEDICINA I ZDRAVSTVO
Temeljne medicinske znanosti
Farmakologija
Znanstveno / umjetničko
područje, polje i grana		BIOMEDICINA I ZDRAVSTVO
Javno zdravstvo i zdravstvena zaštita
Obiteljska medicina
Sažetak (engleski)
The prescribing of medicines is a fundamental component of care for the elderly; however, there is increasing concern with polypharmacy and its impact on morbidity, mortality and costs. As a result, long-term prescription-medicine use and the prevalence of polypharmacy in the elderly in the Republic of Srpska were analyzed. The findings were subsequently used to suggest potential future measures. A retrospective study of all elderly patients during 2005-2010 stratified by age group (three... Više groups), sex and long-term medicine use was performed. Polypharmacy (five or more medicines) increased from 1.4% of the elderly taking medicines long-term to 3.6% by 2010, with 53.6% of elderly taking two or more medicines long-term. The most prevalent diseases were cardiovascular diseases and diabetes. Most prescriptions were in accordance with recent guidelines; however, there was a concern with appreciable prescribing of digoxin and aminophylline. Whilst polypharmacy rates are low in the Republic, the increasing rate is a concern. Further studies are planned. Sakrij dio sažetka
Ključne riječi (engleski)
Jezikengleski
Vrsta publikacijeZnanstveni rad - Izvorni znanstveni rad
Status objaveObjavljen
Vrsta recenzijeRecenziran - međunarodna recenzija
Verzija publikacijeZavršna verzija rukopisa prihvaćena za objavljivanje (postprint)
Naslov časopisaExpert Review of Pharmacoeconomics & Outcomes Research
Brojčani podacivol. 16, br. 5, str. 609-618
p-ISSN1473-7167
e-ISSN1744-8379
DOIhttps://doi.org/10.1586/14737167.2016.1115347
URN:NBNurn:nbn:hr:184:499506
Datum objave publikacije2015-12-15
URL dokumentahttps://www.tandfonline.com/doi/full/10.1586/14737167.2016.1115347
Vrsta resursaTekst
Prava pristupaOtvoreni pristup
Uvjeti korištenjaIkona licence Imenovanje-Nekomercijalno-Bez prerada 4.0 međunarodna (CC BY-NC-ND 4.0)
Datum i vrijeme pohrane2022-03-03 09:24:25
accessibility

closePristupačnostrefresh

Ako želite spremiti trajne postavke, kliknite Spremi, ako ne - vaše će se postavke poništiti kad zatvorite preglednik.